NovoCure (NVCR) Stock Forecast, Price Target & Predictions
NVCR Stock Forecast
NovoCure stock forecast is as follows: an average price target of $68.92 (represents a 303.28% upside from NVCR’s last price of $17.09) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
NVCR Price Target
NVCR Analyst Ratings
Hold
NovoCure Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 16, 2024 | Emily Bodnar | H.C. Wainwright | - | - | 68.73% | 75.54% |
Jul 26, 2024 | Emily Bodnar | H.C. Wainwright | - | - | 31.47% | 40.43% |
May 03, 2024 | Emily Bodnar | H.C. Wainwright | - | - | 55.04% | 28.73% |
May 02, 2024 | Vijay Kumar | Evercore ISI | - | - | -1.89% | -15.16% |
Apr 10, 2024 | Jason Bednar | Piper Sandler | - | - | 88.17% | 63.84% |
Apr 03, 2024 | Larry Biegelsen | Wells Fargo | - | - | 191.87% | 145.76% |
Mar 27, 2024 | H.C. Wainwright | - | - | 63.93% | 40.43% | |
Jan 06, 2023 | J.P. Morgan | - | - | -9.21% | 479.29% | |
Jan 06, 2023 | Wells Fargo | - | - | -9.94% | 526.10% | |
Jan 05, 2023 | Emily Bodnar | H.C. Wainwright | - | - | 30.31% | 719.19% |
10
NovoCure Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 7 |
Avg Price Target | - | $30.00 | $26.36 |
Last Closing Price | $17.09 | $17.09 | $17.09 |
Upside/Downside | -100.00% | 75.54% | 54.24% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Oct 16, 2024 | H.C. Wainwright | Neutral | Buy | Upgrade |
Jul 26, 2024 | H.C. Wainwright | Neutral | Neutral | Hold |
Jul 02, 2024 | Piper Sandler | Neutral | Neutral | Hold |
Jul 02, 2024 | H.C. Wainwright | Underperform | Underperform | Hold |
Jun 04, 2024 | Wells Fargo | Neutral | Neutral | Hold |
May 24, 2024 | Piper Sandler | Overweight | Overweight | Hold |
May 03, 2024 | H.C. Wainwright | Neutral | Neutral | Hold |
May 02, 2024 | Wells Fargo | Buy | Buy | Hold |
May 02, 2024 | Evercore ISI | Negative | Negative | Hold |
10
NovoCure Financial Forecast
NovoCure Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $127.32M | $126.05M | $122.18M | $128.43M | $131.00M | $140.87M | $137.55M | $133.21M | $133.61M | $133.52M | $134.69M | $143.95M | $132.66M | $115.92M | $101.83M | $99.23M | $92.06M | $86.71M | $73.31M | $52.13M | $34.88M |
Avg Forecast | $162.05M | $159.55M | $156.85M | $155.00M | $153.04M | $143.95M | $135.83M | $131.44M | $133.80M | $128.75M | $124.25M | $127.77M | $128.40M | $130.61M | $134.97M | $134.08M | $133.00M | $141.27M | $141.50M | $138.70M | $144.00M | $119.51M | $105.70M | $101.92M | $99.20M | $86.94M | $78.98M | $72.74M | $44.66M | $39.86M |
High Forecast | $165.62M | $163.06M | $160.30M | $160.29M | $155.89M | $143.99M | $135.83M | $131.44M | $133.85M | $137.79M | $126.99M | $130.58M | $131.23M | $130.61M | $134.97M | $134.08M | $133.00M | $141.27M | $141.50M | $138.70M | $144.00M | $119.51M | $105.70M | $101.92M | $99.20M | $86.94M | $78.98M | $72.74M | $53.59M | $47.84M |
Low Forecast | $158.76M | $156.31M | $153.66M | $149.52M | $150.51M | $143.90M | $135.83M | $131.44M | $133.75M | $123.39M | $121.73M | $125.17M | $125.79M | $130.61M | $134.97M | $134.08M | $133.00M | $141.27M | $141.50M | $138.70M | $144.00M | $119.51M | $105.70M | $101.92M | $99.20M | $86.94M | $78.98M | $72.74M | $35.73M | $31.89M |
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 1 | 1 | 2 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 15 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.99% | 1.01% | 0.96% | 1.00% | 1.00% | 1.04% | 1.03% | 1.00% | 0.95% | 0.94% | 0.97% | 1.00% | 1.11% | 1.10% | 1.00% | 1.00% | 1.06% | 1.10% | 1.01% | 1.17% | 0.88% |
Forecast
NovoCure EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 1 | 1 | 2 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 15 |
EBITDA | - | - | - | - | - | - | - | - | - | $-55.44M | $-62.66M | $-60.25M | $-42.98M | $-21.95M | $-18.47M | $1.80M | $-22.91M | $-7.80M | $-10.76M | $-364.00K | $11.30M | $13.23M | $6.65M | $-3.92M | $875.00K | $3.23M | $2.09M | $-6.56M | $-15.33M | $-14.16M |
Avg Forecast | $-13.04M | $-12.84M | $-12.62M | $-12.47M | $-12.31M | $-11.58M | $-10.93M | $-2.66M | $-10.76M | $-10.36M | $-10.00M | $-2.41M | $-13.86M | $-14.03M | $-14.50M | $-2.58M | $-14.29M | $-15.18M | $-15.20M | $-1.31M | $-15.47M | $-12.84M | $-11.36M | $-4.32M | $-10.66M | $-9.34M | $-8.49M | $-7.03M | $-12.76M | $-15.93M |
High Forecast | $-12.77M | $-12.58M | $-12.36M | $-12.03M | $-12.11M | $-11.58M | $-10.93M | $-2.12M | $-10.76M | $-9.93M | $-9.79M | $-1.93M | $-11.09M | $-14.03M | $-14.50M | $-2.07M | $-14.29M | $-15.18M | $-15.20M | $-1.05M | $-15.47M | $-12.84M | $-11.36M | $-3.45M | $-10.66M | $-9.34M | $-8.49M | $-5.62M | $-10.21M | $-12.74M |
Low Forecast | $-13.32M | $-13.12M | $-12.90M | $-12.90M | $-12.54M | $-11.58M | $-10.93M | $-3.19M | $-10.77M | $-11.09M | $-10.22M | $-2.90M | $-16.63M | $-14.03M | $-14.50M | $-3.10M | $-14.29M | $-15.18M | $-15.20M | $-1.57M | $-15.47M | $-12.84M | $-11.36M | $-5.18M | $-10.66M | $-9.34M | $-8.49M | $-8.43M | $-15.32M | $-19.11M |
Surprise % | - | - | - | - | - | - | - | - | - | 5.35% | 6.27% | 24.95% | 3.10% | 1.56% | 1.27% | -0.70% | 1.60% | 0.51% | 0.71% | 0.28% | -0.73% | -1.03% | -0.59% | 0.91% | -0.08% | -0.35% | -0.25% | 0.93% | 1.20% | 0.89% |
Forecast
NovoCure Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 1 | 1 | 2 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 15 |
Net Income | - | - | - | - | - | - | - | - | - | $-49.48M | $-57.42M | $-53.06M | $-37.30M | $-26.58M | $-24.01M | $-4.65M | $-26.46M | $-13.12M | $-14.64M | $-4.13M | $4.92M | $9.28M | $1.66M | $3.95M | $4.26M | $1.93M | $-1.27M | $-12.15M | $-20.72M | $-18.05M |
Avg Forecast | $-44.38M | $-40.77M | $-41.13M | $-41.49M | $-38.35M | $-36.13M | $-43.61M | $-7.65M | $-56.44M | $-56.83M | $-54.12M | $-6.95M | $-16.01M | $-28.16M | $-15.62M | $-7.44M | $-11.04M | $-7.95M | $943.56K | $-14.86M | $13.52M | $4.19M | $-403.88K | $4.35M | $1.69M | $-4.77M | $-7.85M | $-13.02M | $-17.26M | $-20.30M |
High Forecast | $-43.21M | $-39.70M | $-40.05M | $-36.61M | $-32.87M | $-35.18M | $-42.46M | $-6.12M | $-50.05M | $-46.99M | $-52.69M | $-5.56M | $-12.81M | $-28.16M | $-15.62M | $-5.95M | $-11.04M | $-7.95M | $943.56K | $-11.89M | $13.52M | $4.19M | $-403.88K | $5.22M | $1.69M | $-4.77M | $-7.85M | $-10.41M | $-13.81M | $-16.24M |
Low Forecast | $-45.65M | $-41.94M | $-42.31M | $-50.04M | $-44.93M | $-37.17M | $-44.86M | $-9.18M | $-64.96M | $-62.29M | $-55.67M | $-8.34M | $-19.21M | $-28.16M | $-15.62M | $-8.92M | $-11.04M | $-7.95M | $943.56K | $-17.83M | $13.52M | $4.19M | $-403.88K | $3.48M | $1.69M | $-4.77M | $-7.85M | $-15.62M | $-20.71M | $-24.36M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.87% | 1.06% | 7.63% | 2.33% | 0.94% | 1.54% | 0.63% | 2.40% | 1.65% | -15.52% | 0.28% | 0.36% | 2.22% | -4.10% | 0.91% | 2.52% | -0.40% | 0.16% | 0.93% | 1.20% | 0.89% |
Forecast
NovoCure SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 1 | 1 | 2 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 15 |
SG&A | - | - | - | - | - | - | - | - | - | $99.85M | $99.27M | $93.11M | $87.70M | $73.90M | $76.42M | $68.39M | $69.99M | $63.81M | $66.90M | $62.48M | $59.72M | $56.42M | $53.87M | $55.44M | $50.55M | $46.54M | $44.96M | $42.57M | $35.46M | $27.18M |
Avg Forecast | $91.09M | $89.69M | $88.17M | $87.13M | $86.03M | $80.91M | $76.35M | $112.55M | $75.21M | $72.37M | $69.84M | $102.31M | $42.35M | $73.42M | $75.87M | $109.43M | $74.76M | $79.41M | $79.54M | $77.97M | $80.94M | $67.18M | $59.41M | $60.99M | $55.76M | $48.87M | $44.40M | $45.61M | $29.53M | $30.58M |
High Forecast | $93.10M | $91.66M | $90.11M | $90.10M | $87.63M | $80.94M | $76.35M | $135.06M | $75.24M | $77.45M | $71.38M | $122.78M | $50.81M | $73.42M | $75.87M | $131.31M | $74.76M | $79.41M | $79.54M | $77.97M | $80.94M | $67.18M | $59.41M | $73.18M | $55.76M | $48.87M | $44.40M | $54.73M | $35.44M | $36.69M |
Low Forecast | $89.24M | $87.86M | $86.38M | $84.05M | $84.61M | $80.89M | $76.35M | $90.04M | $75.18M | $69.36M | $68.42M | $81.85M | $33.88M | $73.42M | $75.87M | $87.54M | $74.76M | $79.41M | $79.54M | $77.97M | $80.94M | $67.18M | $59.41M | $48.79M | $55.76M | $48.87M | $44.40M | $36.49M | $23.62M | $24.46M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.38% | 1.42% | 0.91% | 2.07% | 1.01% | 1.01% | 0.63% | 0.94% | 0.80% | 0.84% | 0.80% | 0.74% | 0.84% | 0.91% | 0.91% | 0.91% | 0.95% | 1.01% | 0.93% | 1.20% | 0.89% |
Forecast
NovoCure EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 1 | 1 | 2 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 15 |
EPS | - | - | - | - | - | - | - | - | - | $-0.46 | $-0.54 | $-0.50 | $-0.36 | $-0.25 | $-0.23 | $-0.04 | $-0.25 | $-0.13 | $-0.14 | $-0.04 | $0.05 | $0.09 | $0.02 | $0.04 | $0.04 | $0.02 | $-0.01 | $-0.13 | $-0.23 | $-0.21 |
Avg Forecast | $-0.41 | $-0.38 | $-0.38 | $-0.38 | $-0.35 | $-0.33 | $-0.40 | $-0.42 | $-0.52 | $-0.53 | $-0.50 | $-0.32 | $-0.30 | $-0.26 | $-0.14 | $-0.18 | $-0.10 | $-0.07 | $0.01 | $0.01 | $0.13 | $0.04 | $-0.00 | $0.03 | $0.02 | $-0.04 | $-0.07 | $-0.14 | $-0.11 | $-0.27 |
High Forecast | $-0.40 | $-0.37 | $-0.37 | $-0.34 | $-0.30 | $-0.32 | $-0.39 | $-0.41 | $-0.46 | $-0.43 | $-0.49 | $-0.31 | $-0.29 | $-0.26 | $-0.14 | $-0.18 | $-0.10 | $-0.07 | $0.01 | $0.01 | $0.13 | $0.04 | $-0.00 | $0.03 | $0.02 | $-0.04 | $-0.07 | $-0.14 | $-0.09 | $-0.22 |
Low Forecast | $-0.42 | $-0.39 | $-0.39 | $-0.46 | $-0.42 | $-0.34 | $-0.41 | $-0.43 | $-0.60 | $-0.58 | $-0.51 | $-0.33 | $-0.31 | $-0.26 | $-0.14 | $-0.18 | $-0.10 | $-0.07 | $0.01 | $0.01 | $0.13 | $0.04 | $-0.00 | $0.03 | $0.02 | $-0.04 | $-0.07 | $-0.14 | $-0.13 | $-0.32 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.88% | 1.08% | 1.55% | 1.19% | 0.96% | 1.59% | 0.24% | 2.44% | 1.76% | -15.98% | -2.67% | 0.40% | 2.31% | -5.33% | 1.17% | 2.55% | -0.45% | 0.14% | 0.91% | 2.09% | 0.78% |
Forecast
NovoCure Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
NVCR | NovoCure | - | - | 303.28% | Hold |
IRTC | iRhythm | - | - | 63.96% | Buy |
TMDX | TransMedics Group | - | - | 59.76% | Buy |
INMD | InMode | - | - | 48.73% | Hold |
LIVN | LivaNova | - | - | 36.36% | Buy |
CNMD | CONMED | - | - | 33.87% | Buy |
NARI | Inari Medical | - | - | 32.88% | Buy |
INSP | Inspire Medical Systems | - | - | 28.66% | Buy |
PODD | Insulet | - | - | 4.58% | Buy |
ITGR | Integer | - | - | 1.56% | Buy |
MASI | Masimo | - | - | -4.31% | Buy |
GMED | Globus Medical | - | - | -6.32% | Buy |
PEN | Penumbra | - | - | -6.50% | Buy |
SWAV | ShockWave Medical | - | - | -22.88% | Hold |